Michael J. Parnham
Impact in
- Toxicology top 1%
- Organoselenium and organotellurium chemistry
- Pharmacology top 1%
- Inflammatory mediators and NSAID effects
Papers in
- Pharmacology 42
- Inflammatory mediators and NSAID effects 32
- Pharmacogenetics and Drug Metabolism 8
- Co-authors
- I.L. BontaVesna Eraković HaberHelmut SiesAndreas von KnethenBernhard BrüneGerd GeißlingerOgnjen ČulićGianpaolo Perletti
- Journals
- Inflammation Research (14 papers)International Journal of Molecular Sciences (8 papers)European Journal of Pharmacology (5 papers)Prostaglandins (4 papers)Expert Opinion on Investigational Drugs (4 papers)
- Partner nations
- GermanyNetherlandsUnited States
In The Last Decade
Michael J. Parnham
153 papers receiving 4.3k citations
Hit Papers
Peers
Comparison fields: 5 of 158
- Toxicology 183
- Pharmacology 729
- Biochemistry 264
- Pharmacology 256
- Biological Psychiatry 71
Countries citing papers authored by Michael J. Parnham
This map shows the geographic impact of Michael J. Parnham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Parnham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Parnham more than expected).
Fields of papers citing papers by Michael J. Parnham
This network shows the impact of papers produced by Michael J. Parnham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Parnham. The network helps show where Michael J. Parnham may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael J. Parnham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 5 | |
| 2 | 2023 | 6 | |
| 3 | 2022 | 16 | |
| 4 | 2020 | 13 | |
| 5 | 2020 | 19 | |
| 6 | 2020 | 31 | |
| 7 | 2020 | 109 | |
| 8 | 2019 | 33 | |
| 9 | 2018 | 15 | |
| 10 | 2017 | 56 | |
| 11 | 2016 | 5 | |
| 12 | 2015 | 28 | |
| 13 | 2015 | 39 | |
| 14 | 2000 | 243 | |
| 15 | Ethical issues in drug research : through a glass darkly | 1996 | 0 |
| 16 | 1993 | 110 | |
| 17 | Pharmacological methods, receptors & chemotherapy | 1986 | 3 |
| 18 | Haemodynamics, hormones & inflammation | 1984 | 2 |
| 19 | Psycho- and neuro-pharmacology | 1983 | 9 |
| 20 | The presence of prostaglandin-like material in carrageenin induced rat hind paw inflammation [proceedings]. | 1977 | 3 |
About Michael J. Parnham
Michael J. Parnham is a scholar working on Pharmacology, Biological Psychiatry, Biochemistry, Pharmacology and Immunology, having authored 158 papers that have together received 4.5k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (32 papers), Asthma and respiratory diseases (16 papers), Eicosanoids and Hypertension Pharmacology (10 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers), Immune Response and Inflammation (9 papers), Pharmacogenetics and Drug Metabolism (8 papers), Cytokine Signaling Pathways and Interactions (8 papers) and Estrogen and related hormone effects (7 papers). The work is most often cited by research in Toxicology (183 citations), Pharmacology (729 citations), Biochemistry (264 citations), Pharmacology (256 citations) and Biological Psychiatry (71 citations). Michael J. Parnham has collaborated with scholars based in Germany, Netherlands and United States. Frequent co-authors include I.L. Bonta, Vesna Eraković Haber, Helmut Sies, Andreas von Knethen, Bernhard Brüne, Gerd Geißlinger, Ognjen Čulić, Gianpaolo Perletti, Evangelos J. Giamarellos‐Bourboulis and Robin Vos. Their work appears in journals such as Inflammation Research, International Journal of Molecular Sciences, European Journal of Pharmacology, Prostaglandins and Expert Opinion on Investigational Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.